Launch week offerEnds in00h00m00s

annual Promonthly Pro

Andrea Antonino Romeo

Head of Analytical Development & Technologies DS/DP

Sulzer (Switzerland)

Switzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Switzerland Professors in Pharmaceutical Chemistry Pharmaceutical Chemistry professors in Switzerland

About

Andrea Antonino Romeo is the Head of Analytical Development & Technologies at Idorsia in Switzerland. His research focuses on pharmacokinetics, drug metabolism, and bioanalysis, as evidenced by his recent publications on intravenous pharmacokinetics, human mass balance studies, and liver-on-a-chip devices. He is actively involved in providing recommendations for industry practices in drug development and evaluation.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Antonino Romeo

Research Interests

Make your next move.

Explore related searches

About

Articles (9)

Non‐Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece

Recommendations on the use of multiple labels in human mass balance studies</b>

Metabolite Bioanalysis in Drug Development: Recommendations from the IQ Consortium Metabolite Bioanalysis Working Group

Evaluation of the drug disposition of RO7049389 with in vitro data and human mass balance supported by physiologically based pharmacokinetic modelling

Absorption, Distribution, Metabolism, and Excretion of [<sup>14</sup>C]iptacopan in Healthy Male Volunteers and in In Vivo and In Vitro Studies

Considerations for Human ADME strategy and design paradigm shift(s) ‐ an Industry white paper

Species-dependent hepatic and intestinal metabolism of selective estrogen receptor degrader LSZ102 by sulfation and glucuronidation

Exploration and Application of a Liver-on-a-Chip Device in Combination with Modelling and Simulation for Quantitative Drug Metabolism Studies

Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies

Make your next move.